News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Myeloma Paper of the Day, July 16th, Suggested by Robert Orlowski
Jul 16, 2025, 09:27

Myeloma Paper of the Day, July 16th, Suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day:

Genomic and immune profiling of prognostic groups in IgM gammopathy reveals novel biomarkers beyond MYD88 L265P e.g. CXCR4, KMT2D, ARID1A and EP300 mutations, upregulated genes involved in NF-κB and BCR signaling activation.”

Title: Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond MYD88 L265P

Authors: David F. Moreno, Ferran Nadeu, Fara Brasó-Maristany, Sergi Vaqué, Sara Paz, Joan Mañé, Oriol Cardús, Elena Medina, Ester Lozano, Luis Gerardo Rodríguez-Lobato, Anna de Daniel, Natalia Tovar, María T. Cibeira, Joan Bladé, Laura Rosiñol, Aleix Prat, Dolors Colomer, Carlos Fernández de Larrea.

You can read the Full Article in Frontiers in Immunology.

Myeloma Paper of the Day, July 16th, Suggested by Robert Orlowski

You can find more posts featuring Robert Orlowski in OncoDaily.

Aleix Prat Anna de Daniel cancer Carlos Fernández de Larrea David F. Moreno Dolors Colomer Elena Medina Ester Lozano Fara Brasó-Maristany Ferran Nadeu IgM gammopathy Joan Bladé Joan Mañé Laura Rosiñol Luis Gerardo Rodríguez-Lobato María T. Cibeira Myeloma Myeloma Paper of the Day Natalia Tovar OncoDaily Oncology Oriol Cardús Robert Orlowski Sara Paz Sergi Vaqué
Special Coverage
Voices
Aug 25, 2025, 14:49
The Future of Cancer Care is About Supporting Patients Through Innovation - SPCC
Voices
Aug 25, 2025, 14:44
Miriam Mutebi: So, Here’s Why Basic and Translational Research Is Important
Voices
Aug 25, 2025, 14:42
Gustavo Viani: A Game Changer in Cervical Cancer RT?
Insight
Aug 25, 2025, 14:34
Philipp Ivanyi Highlights Need for Reconsideration in Cancer Treatment Landscape
Voices
Aug 25, 2025, 14:32
Douglas Flora: America Is Abandoning One of the Greatest Medical Breakthroughs
Insight
Aug 25, 2025, 14:21
Anirban Maitra Highlights New Paper on Therapeutic Targets for Pancreatic Cancer
OncoDaily Pulse
Aug 25, 2025, 14:16
Padraic O’Malley: Meet the Experts of VIRO 2025
Insight
Aug 25, 2025, 14:15
Hidden Risks: BRCA Mutations and Breast Implants - CancerWorld
Voices
Aug 25, 2025, 13:49
Mario I Fernandez: Joining LATAM Bladder Cancer Experts at the IBCG in Houston
Voices
Aug 25, 2025, 13:34
Gevorg Tamamyan: Hemostasis Today - A New Era in Hemostasis and Thrombosis Reporting
Career Updates
Aug 25, 2025, 13:16
Jouliana Sadek Joins the Kyowa Kirin North America Team as Associate Director, Medical Value Outcomes Liaison
FDA Approvals
Aug 25, 2025, 13:00
FDA Breakthrough Therapy Designation for Iza-bren: Advancing Treatment for EGFR-Mutant NSCLC